{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:25:59Z","timestamp":1784204759674,"version":"3.55.0"},"reference-count":14,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijn.ijn_12_18","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T09:45:43Z","timestamp":1537350343000},"page":"62","source":"Crossref","is-referenced-by-count":7,"title":["Systemic lupus erythematosus and myasthenia gravis: A rare association"],"prefix":"10.25259","volume":"29","author":[{"given":"J","family":"Dhanapriya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AT","family":"Maasila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Dineshkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Sakthirajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Rajasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Balasubramaniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.241565-1","first-page":"445","volume-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","author":"Zhang","year":"2012","journal-title":"Arch Neurol"},{"key":"key-10.4103\/0971-4065.241565-2","first-page":"799","volume-title":"Systemic lupus erythematosus followed by myasthenia gravis: A rare association","author":"S\u00eerbu","year":"2013","journal-title":"Cent Eur J Med"},{"key":"key-10.4103\/0971-4065.241565-3","first-page":"230","volume-title":"Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus","author":"McDonagh","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/0971-4065.241565-4","first-page":"486","volume-title":"Association between myasthaenia gravis and systemic lupus erythematosus: Three case reports and review of the literature","author":"Castrej\u00f3n","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"key-10.4103\/0971-4065.241565-5","unstructured":"Vinagre F, Santos MJ, Silva JC. Systemic lupus erythematosus with muscle weakness due to myasthenia gravis Acta Reumatologica Port 2006;31:167-72."},{"key":"key-10.4103\/0971-4065.241565-6","first-page":"1290","volume-title":"The association of systemic lupus erythematosus and myasthenia gravis: A series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature","author":"Jallouli","year":"2012","journal-title":"J Neurol"},{"key":"key-10.4103\/0971-4065.241565-7","first-page":"134","volume-title":"Appearance of systemic lupus erythematosus in patients with myasthenia gravis following thymectomy: Two case reports","author":"Park","year":"2004","journal-title":"J Korean Med Sci"},{"key":"key-10.4103\/0971-4065.241565-8","first-page":"4","volume-title":"High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: A clinical and serologic study","author":"Sthoeger","year":"2006","journal-title":"Am J Med Sci"},{"key":"key-10.4103\/0971-4065.241565-9","first-page":"1064","volume-title":"Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus","author":"Hostmann","year":"2008","journal-title":"Lupus"},{"key":"key-10.4103\/0971-4065.241565-10","doi-asserted-by":"crossref","unstructured":"Kigawa N, Pineau C, Clarke AE, Nashi E, Vinet E, Veilleux M, et al. Development of myasthenia gravis in systemic lupus erythematosus. EJCRIM 2014;1: Doi: 10.12890\/2014_000020.","DOI":"10.12890\/2014_000020"},{"key":"key-10.4103\/0971-4065.241565-11","first-page":"41","volume-title":"Quantification and molecular characterization of regulatory T cells in connective tissue diseases","author":"Banica","year":"2009","journal-title":"Autoimmunity"},{"key":"key-10.4103\/0971-4065.241565-12","first-page":"385","volume-title":"Antimalarial myopathy: An underdiagnosed complication.Prospective longitudinal study of 119 patients?","author":"Casado","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/0971-4065.241565-13","first-page":"E294","volume-title":"Up-regulated expression of fas antigen in peripheral T cell subsets in patients with myasthenia gravis","author":"Mai","year":"2012","journal-title":"Clin Invest Med"},{"key":"key-10.4103\/0971-4065.241565-14","first-page":"432","volume-title":"The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis","author":"Meraouna","year":"2006","journal-title":"Blood"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:43:18Z","timestamp":1712173398000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/systemic-lupus-erythematosus-and-myasthenia-gravis-a-rare-association\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"alternative-id":["241565"],"URL":"https:\/\/doi.org\/10.4103\/ijn.ijn_12_18","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}